JANX vs ZBIO

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Jul 20, 2026

JANX

63.9
AI Score
VS
JANX Wins

ZBIO

61.9
AI Score

Investment Advisor Scores

JANX

64score
Recommendation
BUY

ZBIO

62score
Recommendation
BUY

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric JANX ZBIO Winner
Net Income -24.36M -377.74M JANX
Operating Income -34.21M -383.06M JANX
ROE -2.6% -156.0% JANX
ROA -2.4% -98.5% JANX
Total Assets 1.03B 383.64M JANX
Cash 51.83M 110.64M ZBIO
Current Ratio 17.01 5.61 JANX
Free Cash Flow -12.61M -172.35M JANX

Relative Price Performance (Last 90 Days)

JANX 1M: -2.1% · 3M: +6.1% ZBIO 1M: +15.0% · 3M: +61.8%

Current Technical Phase

JANX

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 48

RSI (14): 47.6 · Price: $15.21

ZBIO

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (22.4% over 20 days), RSI 60

RSI (14): 60.1 · Price: $31.33

Fundamentals Snapshot

Metric JANX ZBIO
Market Cap
Forward P/E -5.6 -13.9
Trailing P/E
Revenue (TTM)
Revenue Growth 21.8% -1.0%
Gross Margin -8.3%
Operating Margin -9.2% 0.0%
EPS -1.91 -9.44
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, JANX is currently the stronger investment candidate, winning 7 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.